C07C 233/62
Having the nitrogen atom of at least one of the carboxamide groups
Official title: having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
C07C233/62 (Having the nitrogen atom of at least one of the carboxamide groups) appears on 119 US grants and 125 published applications in this corpus.
Search patents in C07C- Granted patents
- 119
- Published applications
- 125
- Assignees
- 98
- Inventors
- 480
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 4 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 4 | 0 |
| 2001 | 2 | 1 |
| 2002 | 4 | 1 |
| 2003 | 4 | 4 |
| 2004 | 3 | 7 |
| 2005 | 3 | 4 |
| 2006 | 2 | 2 |
| 2007 | 2 | 3 |
| 2008 | 4 | 6 |
| 2009 | 0 | 5 |
| 2010 | 4 | 6 |
| 2011 | 3 | 3 |
| 2012 | 5 | 9 |
| 2013 | 8 | 5 |
| 2014 | 5 | 5 |
| 2015 | 2 | 0 |
| 2016 | 3 | 5 |
| 2017 | 4 | 5 |
| 2018 | 4 | 9 |
| 2019 | 3 | 2 |
| 2020 | 6 | 3 |
| 2021 | 1 | 8 |
| 2022 | 5 | 4 |
| 2023 | 2 | 5 |
| 2024 | 4 | 15 |
| 2025 | 4 | 2 |
| 2026 | 4 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Small-cell polystyrene foams, and process for producing same19 May 2026US 12,630,693 B2Ineos Styrolution Group GmbH
- Cyclohexane lipidoids for nucleic acid transfection and use thereof21 Apr 2026US 12,605,464 B2Ustav Organicke Chemie A Biochemie Av Cr, V. V. I.
- Lipidoids for nucleic acid transfection and use thereof24 Feb 2026US 12,559,450 B2Ustav Organicke Chemie A Biochemie Av Cr, V. V. I.
- 9H-fluorene derivatives or their pharmaceutically acceptable salts9 Dec 2025US 12,492,163 B2Uniwersytet Jagiellonski
- Ionizable lipids with malonate tails16 Jul 2026US 2026/0199239 A1ModernaTX, Inc.
- Cycloalkane-based lipid compound for delivering nucleic acids, and lipid nanoparticles comprising same9 Jul 2026US 2026/0193172 A1The Green Cross Corporation
- Lipid compound and composition for delivery of active substance2 Jul 2026US 2026/0184669 A1Korea Research Institute of Bioscience and Biotechnology
- Lipidoids for nucleic acid transfection and use thereof25 Jun 2026US 2026/0176231 A1Ustav Organicke Chemie A Biochemie Av Cr, V. V. I.
- N-(benzhydryl)cycloalkylcarboxamide derivatives as inhibitors of glycogen synthase 1 (gys1) and methods of use thereof26 Mar 2026US 2026/0085034 A1Maze Therapeutics, Inc.
Most cited
By later US patents
- Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method125US 5,760,246 A1998
- Paving compositions and methods for their use59US 6,786,963 B2BJ Services Company · 2004
- Aniline derivatives35US 7,879,863 B2Ajinomoto Co., Inc. · 2011
- Substituted basic 2-aminotetralin useful as cardiotonic agents31US 4,880,802 ABayer Aktiengesellschaft · 1989
- Pharmaceutical composition for antagonizing CCR5 comprising anilide derivative30US 6,268,354 B1Takeda Chemical Industries, Ltd. · 2001